164 related articles for article (PubMed ID: 17120363)
1. Low-down on link between bone-builders and jaw damage.
Johns Hopkins Med Lett Health After 50; 2006 Sep; 18(7):1-2. PubMed ID: 17120363
[No Abstract] [Full Text] [Related]
2. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
Radfar L; Masood F
J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
[TBL] [Abstract][Full Text] [Related]
3. [Diphosphonate therapy and osteonecrosis of the jaw].
Løkken P; Skoglund LA; Skjelbred P
Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
[No Abstract] [Full Text] [Related]
4. Bisphosphonates and avascular necrosis of alveolar bone: a potential threat to dental implants.
Garg AK
Dent Implantol Update; 2006 Oct; 17(10):73-8. PubMed ID: 17066981
[No Abstract] [Full Text] [Related]
5. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
Bamias A; Terpos E; Dimopoulos MA
Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090
[No Abstract] [Full Text] [Related]
6. [Osteonecrosis of the jaw].
Eriksen EF
Ugeskr Laeger; 2009 Feb; 171(8):629; author reply 629. PubMed ID: 19291862
[No Abstract] [Full Text] [Related]
7. Specialists play down risk of jaw condition.
Stassen LF
J Ir Dent Assoc; 2008; 54(4):153. PubMed ID: 18780680
[No Abstract] [Full Text] [Related]
8. Osteonecrosis of the jaw.
Sykes DL
Dent Today; 2007 Feb; 26(2):16. PubMed ID: 17348272
[No Abstract] [Full Text] [Related]
9. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
Aragon-Ching JB; Dahut WL
Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325
[No Abstract] [Full Text] [Related]
10. Do Fosamax-type drugs increase the risk of osteonecrosis of the jaw for patients receiving dental implants?
Wynn RL
Gen Dent; 2008; 56(5):410-1. PubMed ID: 18683394
[No Abstract] [Full Text] [Related]
11. Standard protocols.
Kini G
Br Dent J; 2007 Oct; 203(8):440. PubMed ID: 17965662
[No Abstract] [Full Text] [Related]
12. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.
Geist RY; Geist JR; Aksu M
J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547
[No Abstract] [Full Text] [Related]
13. Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity.
Marx RE
Int J Periodontics Restorative Dent; 2008 Feb; 28(1):5-6. PubMed ID: 18351197
[No Abstract] [Full Text] [Related]
14. Oral bisphosphonates and osteonecrosis of the jaw.
Wynn RL
Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956
[No Abstract] [Full Text] [Related]
15. Bisphosphonates and bone...what have we learned?
Guttenberg SA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):769-72. PubMed ID: 18835534
[No Abstract] [Full Text] [Related]
16. Bisphosphonate treatment as a cause of jaw osteonecrosis.
Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
[No Abstract] [Full Text] [Related]
17. Osteonecrosis: what dentists need to know.
Thoman RD
Hawaii Dent J; 2006; 37(6):9-10, 12-3. PubMed ID: 17290948
[No Abstract] [Full Text] [Related]
18. An unavoidable and unmistakable link.
Rossi MS
N Y State Dent J; 2006; 72(5):6-8. PubMed ID: 17036580
[No Abstract] [Full Text] [Related]
19. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
Fusco V; Baraldi A; Loidoris A; Ciuffreda L; Galassi C; Goia F; Scoletta M; Berrone S; Benech A; Ortega C; Berruti A;
J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
[No Abstract] [Full Text] [Related]
20. The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line.
Assael LA
J Oral Maxillofac Surg; 2007 Jul; 65(7):1275-6. PubMed ID: 17577488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
